Comparing of the Pharmacokinetic, Pharmacodynamic, Safety and Immunogenicity of HS-20090 and Xgeva® in Healthy Adults

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
A randomized, double-blind and parallel group study to compare the pharmacokinetic, pharmacodynamic, safety and immunogenicity of HS-20090 120mg(1.7ml)and Xgeva® in healthy adults.
Epistemonikos ID: 9eefd9b0cf080e643d8ffc81618ef1491dbaa97f
First added on: May 07, 2024